Company record
Padagis US LLC
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Padagis US LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 22 | Class II | Padagis US LLC Drug |
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35 Subpotent Drug: Low out of specification assay results performed during long-term stability testing. |